Product Description
Overall, the global hemostasis device market was valued at $685.8 million in 2021. This is expected to increase over the forecast period at a CAGR of 4.6% to reach $939.8 million.
The full report suite on the global market for hemostasis devices includes hemostasis probes, ligation devices and sclerotherapy needles.
MARKET REPORT DATA TYPES INCLUDED
- Unit Sales, Average Selling Prices, Market Size & Growth Trends
- Procedure Numbers
- COVID-19 Impact Analysis
- Market Drivers & Limiters
- Market Forecasts Until 2028, and Historical Data to 2018
- Recent Mergers & Acquisitions
- Company Profiles and Product Portfolios
- Leading Competitors
PROCEDURE NUMBERS
The prevalence of unexpected gastrointestinal bleeding has been declining. However, population growth will continue to drive growth in the number of procedures being performed. Gastrointestinal bleeding is also more prevalent in older populations, with the prevalence rates among those who are older than 75 being almost 20 times higher than among individuals younger than 65. As the baby boomer generation ages, the percentage of the population that is more prone to gastrointestinal bleeding is expected to rise, further increasing the number of procedures performed.
GLOBAL HEMOSTASIS DEVICE MARKET TRENDS
As the global population continues to age, diseases such as cirrhosis and hepatitis are becoming more prevalent. These diseases often cause gastrointestinal bleeding; hemostasis devices must be used to counteract this bleeding. Prevalence rates among the population for conditions that cause GI bleeding are also increasing, due to the unhealthy lifestyles.
GLOBAL HEMOSTASIS DEVICE MARKET SHARE INSIGHTS
Overall, within the global hemostasis device market there are three dominant competitors: Boston Scientific, Cook Medical, and Micro-Tech Endoscopy.
In 2021, the leading competitor in the hemostasis device market was Boston Scientific. The company held share across all segments. After the launch of the Resolution 360™ ligation clip in 2016, the company added the Resolution 360™ ULTRA to its product portfolio in November 2020, cementing its leading market share even further.
GLOBAL HEMOSTASIS DEVICE MARKET SEGMENTATION SUMMARY
- Hemostasis Probes
- Ligation Devices
- Sclerotherapy Needles
Research Scope Summary
| Report Attribute | Details |
|---|---|
| Regions | North America (Canada, United States) Latin America (Argentina, Brazil, Chile, Colombia, Mexico, Peru, Venezuela) Western Europe (Austria, Benelux, France, Germany, Italy, Portugal, Scandinavia, Spain, Switzerland, U.K.) Central & Eastern Europe (Baltic States, Bulgaria, Croatia, Czech Republic, Greece, Hungary, Kazakhstan, Poland, Romania, Russia, Turkey, Ukraine) Middle East (Bahrain, Iran, Israel, Kuwait, Oman, Qatar, Saudi Arabia, United Arab Emirates) Asia Pacific (Australia, Cambodia, China, Hong Kong, India, Indonesia, Japan, Malaysia, Myanmar, New Zealand, Philippines, Singapore, South Korea, Taiwan, Thailand, Vietnam) Africa (Algeria, Egypt, Ghana, Kenya, Libya, Morocco, Nigeria, South Africa, Sudan, Uganda) |
| Base Year | 2021 |
| Forecast Period | 2022-2028 |
| Historical Data | 2018-2021 |
| Quantitative Data | Market Size, Market Share, Market Growth Rates, Units Sold, Average Selling Prices |
| Qualitative Data | COVID-19 Impact, Market Growth Trends, Market Limiters, Competitive Analysis & SWOT for Top Competitors, Mergers & Acquisitions, Company Profiles, Product Portfolios |
| Data Sources | Primary Interviews with Industry Leaders, Government Physician Data, Regulatory Data, Hospital Private Data, Import & Export Data.
Read more about iData’s 9-Step Research Methodology |
WHY CHOOSE iDATA?
- Experts Only – iData has been around for over 17 years and is the trusted source of intelligence, and data-driven insights for key industry players. We are made up of specialists with a sole focus on medical devices, dental devices and pharmaceuticals. Our research and consulting field of endeavour never strays from the medical device industry and, because of this, we are the number one choice for leading companies in this field.
- Global Coverage – iData’s unique methodology, and its expansion to over 70 countries world-wide, has made it one of the most viable sources of intelligence for global companies along with those who plan to expand their portfolio beyond the confines of their own country. Providing procedural data at the country level is another testimony to the trusted global coverage we provide.
- Attention to Detail – It’s our attention to small details, scheduling of timelines, and keen project management that makes us stand out from the rest. We are creative, and our reports include metrics such as procedure numbers, ASPs, and SKU-level insights that are not found elsewhere.
- Pricing – When comparing like-with-like, iData’s prices are not only extremely competitive but also the most cost-effective. We strive for success and want the same for our clients. With the level of detail incorporated into each report alongside the extensive segmentation provided, no other report compares at our price point.
